110 related articles for article (PubMed ID: 12412612)
1. Re: Recommendations for the appropriate use of anti-inflammatory drugs in the era of the coxibs: defining the role of the gastroprotective agents.
Laupacis A; Naglie G
Can J Gastroenterol; 2002 Sep; 16(9):651; author reply 651-2. PubMed ID: 12412612
[No Abstract] [Full Text] [Related]
2. Recommendations for the appropriate use of anti-inflammatory drugs in the era of the coxibs: defining the role of gastroprotective agents.
Hunt RH; Barkun AN; Baron D; Bombardier C; Bursey FR; Marshall JR; Morgan DG; Paré P; Thomson AB; Whittaker JS
Can J Gastroenterol; 2002 Apr; 16(4):231-40. PubMed ID: 11981576
[TBL] [Abstract][Full Text] [Related]
3. NSAIDs, risks, and gastroprotective strategies: current status and future.
Graham DY; Chan FK
Gastroenterology; 2008 Apr; 134(4):1240-6. PubMed ID: 18395101
[No Abstract] [Full Text] [Related]
4. Reducing NSAID-induced gastrointestinal complications.
Drug Ther Bull; 2011 Feb; 49(2):18-21; quiz i-ii. PubMed ID: 21304164
[TBL] [Abstract][Full Text] [Related]
5. Impact of selective cyclooxygenase-2 inhibitors on anti-ulcer medication and non-steroidal anti-inflammatory drug use in patients with rheumatic disease.
Fenn GC; Grobler M; Schaffer D
Intern Med J; 2004 Nov; 34(11):647-9; discussion 650. PubMed ID: 15546461
[No Abstract] [Full Text] [Related]
6. Underutilization of gastroprotective measures in patients receiving nonsteroidal antiinflammatory drugs.
Smalley W; Stein CM; Arbogast PG; Eisen G; Ray WA; Griffin M
Arthritis Rheum; 2002 Aug; 46(8):2195-200. PubMed ID: 12209525
[TBL] [Abstract][Full Text] [Related]
7. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.
Ray WA; Chung CP; Stein CM; Smalley WE; Hall K; Arbogast PG; Griffin MR
Gastroenterology; 2007 Sep; 133(3):790-8. PubMed ID: 17854591
[TBL] [Abstract][Full Text] [Related]
8. Appropriateness of NSAID and Coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario: results from the CANOAR study.
Sebaldt RJ; Petrie A; Goldsmith CH; Marentette MA
Am J Manag Care; 2004 Nov; 10(11 Pt 1):742-50. PubMed ID: 15623264
[TBL] [Abstract][Full Text] [Related]
9. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
Chan FK; Graham DY
Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
[TBL] [Abstract][Full Text] [Related]
10. [The lack of awareness of the Israeli population regarding gastrointestinal complications from non-steroidal anti-inflammatory drugs].
Zandman-Goddard G; Langevitz P
Harefuah; 2001 Jun; 140(6):476-8, 567, 566. PubMed ID: 11420844
[TBL] [Abstract][Full Text] [Related]
11. Management pattern for patients with osteoarthritis treated with traditional non-steroidal anti-inflammatory drugs in Spain prior to introduction of Coxibs.
Arboleya LR; de la Figuera E; Soledad García M; Aragón B;
Curr Med Res Opin; 2003; 19(4):278-87. PubMed ID: 12841920
[TBL] [Abstract][Full Text] [Related]
12. Impact of selective cyclooxygenase-2 inhibitors on anti-ulcer medication and non-steroidal anti-inflammatory drug use in patients with rheumatic disease.
Joshua FF; Oakley SP; Major GA
Intern Med J; 2004 Apr; 34(4):153-61. PubMed ID: 15086694
[TBL] [Abstract][Full Text] [Related]
13. Physicians' approaches to the use of gastroprotective strategies in low-risk non-steroidal anti-inflammatory drug users.
Murthy SK; Kauldher S; Targownik LE
Aliment Pharmacol Ther; 2006 May; 23(9):1365-72. PubMed ID: 16629943
[TBL] [Abstract][Full Text] [Related]
14. An evidence-based approach to prescribing nonsteroidal antiinflammatory drugs. Third Canadian Consensus Conference.
Tannenbaum H; Bombardier C; Davis P; Russell AS;
J Rheumatol; 2006 Jan; 33(1):140-57. PubMed ID: 16331802
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal events related to the use of non-steroidal anti-inflammatory drugs: some clinical and economic aspects.
Eliakim R; Rachmilewitz D
Isr J Med Sci; 1997 Oct; 33(10):696-9. PubMed ID: 9397147
[No Abstract] [Full Text] [Related]
16. [Recommendations for treatment with nonsteroidal anti-inflammatory drugs].
Bolten WW
MMW Fortschr Med; 2005 Aug; 147(31-32):24-7. PubMed ID: 16128192
[TBL] [Abstract][Full Text] [Related]
17. The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs.
Targownik LE; Metge CJ; Leung S; Chateau DG
Gastroenterology; 2008 Apr; 134(4):937-44. PubMed ID: 18294634
[TBL] [Abstract][Full Text] [Related]
18. Underutilization of gastroprotective drugs in patients receiving non-steroidal anti-inflammatory drugs.
Thiéfin G; Schwalm MS
Dig Liver Dis; 2011 Mar; 43(3):209-14. PubMed ID: 21051300
[TBL] [Abstract][Full Text] [Related]
19. COXIBs and non-selective NSAIDs in the gastroenterological setting: what should patients and physicians do?
Lazzaroni M; Battocchia A; Bianchi Porro G
Dig Liver Dis; 2007 Jun; 39(6):589-96. PubMed ID: 17459794
[TBL] [Abstract][Full Text] [Related]
20. Use of NSAIDs, COX-2 inhibitors, and acetaminophen and associated coprescriptions of gastroprotective agents in an elderly population.
Rahme E; Marentette MA; Kong SX; Lelorier J
Arthritis Rheum; 2002 Dec; 47(6):595-602. PubMed ID: 12522832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
